미국의 세포배양 보충제 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 최종 용도별, 부문 예측(2025-2033년)

U.S. Cell Culture Supplements Market Trends:

The U.S. cell culture supplements market size was valued at USD 813.3 million in 2024 and is anticipated to reach USD 2304.8 million by 2033, growing at a CAGR of 12.76% from 2025 to 2033, driven by increasing demand for biopharmaceuticals, advancements in cell culture technologies, and expanding research activities in regenerative medicine and cell-based therapies.

U.S. Cell Culture Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. cell culture supplements market on the basis of product type, application, and end use:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Serum-Based Supplements
  • Protein-Based & Recombinant Supplements
  • Chemically Defined Supplements
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Drug Discovery
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Culture Media Manufacturers
  • Pharmaceutical & Biotechnology Companies
  • CDMOs/ CMOs & CROs
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Type Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Cell Culture Supplements Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth of cell and gene therapy
    • 3.2.1.2. Rising biologics and biosimilars production
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of GMP-grade and specialty supplements
    • 3.2.2.2. Regulatory and standardization challenges
• 3.3. U.S. Cell Culture Supplements Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Supplements Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Cell Culture Supplements Market Product Type Movement Analysis
• 4.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
• 4.4. Serum-Based Supplements
  • 4.4.1. Serum-Based Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.5. Protein-Based & Recombinant Supplements
  • 4.5.1. Protein-Based & Recombinant Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.6. Chemically Defined Supplements
  • 4.6.1. Kits & Reagents Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Supplements Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Cell Culture Supplements Market Application Movement Analysis
• 5.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Biopharmaceutical Manufacturing
  • 5.4.1. Biopharmaceuticals Manufacturing Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.5. Cell & Gene Therapy
  • 5.5.1. Cell & Gene Therapy Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.6. Drug Discovery
  • 5.6.1. Drug Discovery Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Supplements Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Cell Culture Supplements Market End Use Movement Analysis
• 6.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Cell Culture Media Manufacturers
  • 6.4.1. Cell Culture Media Manufacturers Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceuticals & Biotechnology Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.6. CDMOs/ CMOs & CROs
  • 6.6.1. CDMOs/ CMOs & CROs Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.7. Academic & Research Institutes
  • 6.7.1. Academic & Research Institutes Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Merck KGaA
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product/Service Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Thermo Fisher Scientific Inc.
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product/Service Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. HiMedia Laboratories
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product/Service Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Danaher
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product/Service Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Sartorius AG
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product/Service Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Corning Inc.
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product/Service Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. R&D Systems (Bio-Techne)
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product/Service Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. STEMCELL Technologies
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product/Service Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Repligen Corporation
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product/Service Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Proteintech Group, Inc
    • 7.4.10.1. Company Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product/Service Benchmarking
    • 7.4.10.4. Strategic Initiatives